The influence of comorbidity on the risk of access-related bacteremia in chronic hemodialysis patients

Hemodialysis International

Volumn 13, Issue 1, 2009, Pages 6-10

  Mazonakis, Emmanouil ^a   Stirling, Catherine ^b   Booth, Karen L ^c   McClenahan, Jenny ^c   Heron, Neil ^c   Geddes, Colin C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bacteremia; Comorbidity; Hemodialysis; Vascular access

Indexed keywords

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETER; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION RATE; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE;

ADULT; AGED; ARTERIOVENOUS SHUNT, SURGICAL; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 59249107482     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00327.x     Document Type: Article

References (21)

1. Besarab A, Work J. National Kidney Foundation-K/DOQI Clinical Practice Guidelines for Vascular Access, Update 2006. Available from: http://www.kidney.org/professionals/kdoqi/guideline_upHD_PD_VA/index.htm (accessed date: October 12, 2008)
2. Mactier RA. The Renal Association Clinical Practice Guidelines, 7.1-7.16, June 2, 2006. Available from: http://www.renal.org/guidelines/ module3a.html#VascularAccess
3. Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant. 2004; 19: 670-677.
4. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002; 61: 305-316.
5. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS wave 2 study. Kidney Int. 2005; 68: 311-318.
6. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004; 15: 477-486.
7. United States Renal Data System. The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. Am J Kidney Dis. 1997; 30(Suppl 1): S160-S177.
8. Metcalfe W, Khan IH, Prescott GJ, Simpson K, Macleod AM. Hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM. 2003; 96: 899-909.
9. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in US haemodialysis patients. Kidney Int. 2001; 60: 1443-1451.
10. Lok CE. Avoiding trouble down the line: The management and prevention of hemodialysis catheter-related infections. Adv Chronic Kidney Dis. 2006; 13: 225-244.
11. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997; 127: 275-280.
12. Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int. 2000; 57: 2151-2155.
13. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998; 9: 869-876.
14. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study. J Am Soc Nephrol. 2002; 13: 2133-2139.
15. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999; 34: 1114-1124.
16. Beathard G. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol. 1999; 10: 1045-1049.
17. Mazonakis E, Stirling C, Wright D, Booth KL, Heron N, Geddes CC. Line related sepsis in haemodialysis patients-Incidence, organisms and subsequent mortality. Scottish Renal Association meeting, Dundee, October 2003.
18. Klevens RM, Tokars JI, Andrus M. Electronic reporting of infections associated with hemodialysis. Nephrol News Issues. 2005; 19: 37-43.
19. Hajjar J, Girard R, Marc JM, et al. Surveillance of infections in chronic hemodialysis patients. Nephrologie. 2004; 25: 133-140.
20. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993; 341: 415-418.
21. Geddes CC, van Dijk PC, McArthur S, et al. The ERA-EDTA cohort study-comparison of methods to predict survival on renal replacement therapy. Nephrol Dial Transplant. 2006; 21: 945-956.